JP2009537624A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009537624A5 JP2009537624A5 JP2009511581A JP2009511581A JP2009537624A5 JP 2009537624 A5 JP2009537624 A5 JP 2009537624A5 JP 2009511581 A JP2009511581 A JP 2009511581A JP 2009511581 A JP2009511581 A JP 2009511581A JP 2009537624 A5 JP2009537624 A5 JP 2009537624A5
- Authority
- JP
- Japan
- Prior art keywords
- abu
- cbp
- contrast agent
- peptide
- ily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0610395.6A GB0610395D0 (en) | 2006-05-25 | 2006-05-25 | Novel imaging agents |
| PCT/GB2007/001964 WO2007138291A2 (en) | 2006-05-25 | 2007-05-25 | Novel imaging agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009537624A JP2009537624A (ja) | 2009-10-29 |
| JP2009537624A5 true JP2009537624A5 (enExample) | 2010-06-17 |
Family
ID=36687722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511581A Ceased JP2009537624A (ja) | 2006-05-25 | 2007-05-25 | 新規造影剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8304388B2 (enExample) |
| EP (1) | EP2026844A2 (enExample) |
| JP (1) | JP2009537624A (enExample) |
| CN (1) | CN101454026B (enExample) |
| BR (1) | BRPI0711937A2 (enExample) |
| GB (1) | GB0610395D0 (enExample) |
| RU (1) | RU2441668C2 (enExample) |
| WO (1) | WO2007138291A2 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5604305B2 (ja) * | 2007-12-13 | 2014-10-08 | アンセルム（アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） | 線維症の非侵襲性の特異的イメージングのための、ポリペプチド、環状ポリペプチドおよびそれを含む医薬 |
| HUE044239T2 (hu) | 2008-03-27 | 2019-10-28 | Purdue Research Foundation | Kollagén-kötõ szintetikus peptidoglikánok, elõállításuk és alkalmazási eljárásaik |
| JP2010215572A (ja) * | 2009-03-17 | 2010-09-30 | Japan Health Science Foundation | 歯髄炎診断マーカー及び歯髄炎診断システム |
| WO2011128931A1 (ja) * | 2010-04-12 | 2011-10-20 | 財団法人ヒューマンサイエンス振興財団 | 歯髄炎診断マーカー及び歯髄炎診断システム |
| US9173919B2 (en) * | 2011-02-16 | 2015-11-03 | Purdue Research Foundation | Collagen-targeted nanoparticles |
| US9217016B2 (en) | 2011-05-24 | 2015-12-22 | Symic Ip, Llc | Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use |
| WO2014055253A1 (en) * | 2012-10-04 | 2014-04-10 | The General Hospital Corporation | Methods of synthesizing and using peg-like fluorochromes |
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| EP2970509B1 (en) | 2013-03-15 | 2020-05-13 | Purdue Research Foundation | Extracellular matrix-binding synthetic peptidoglycans |
| US20140294901A1 (en) * | 2013-04-02 | 2014-10-02 | Protagonist Therapeutics, Inc. | Novel a4b7 peptide dimer antagonists |
| US20140294902A1 (en) * | 2013-04-02 | 2014-10-02 | Protagonist Therapeutics, Inc. | Novel a4b7 peptide antagonists |
| WO2015164822A1 (en) | 2014-04-25 | 2015-10-29 | Purdue Research Foundation | Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction |
| CA2949215C (en) | 2014-05-16 | 2023-03-14 | Protagonist Therapeutics, Inc. | .alpha.4.beta.7 integrin thioether peptide antagonists |
| SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| WO2016054445A1 (en) | 2014-10-01 | 2016-04-07 | Protagonist Therapeutics, Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
| JP2017535527A (ja) | 2014-10-01 | 2017-11-30 | プロタゴニスト セラピューティクス， インコーポレイテッド | 新規のα４β７ペプチド単量体及び二量体拮抗薬 |
| EP3250240A4 (en) * | 2015-01-30 | 2018-10-10 | University of Utah Research Foundation | Dimeric collagen hybridizing peptides and methods of using |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3009834A1 (en) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2017184683A1 (en) * | 2016-04-21 | 2017-10-26 | The Board Of Regents Of The University Of Taxas System | Methods and compositions for detecting aneurysms |
| WO2018022937A1 (en) | 2016-07-27 | 2018-02-01 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| WO2019010484A2 (en) | 2017-07-07 | 2019-01-10 | Symic Ip, Llc | SYNTHETIC BIOCONJUGATES |
| WO2019044894A1 (ja) * | 2017-08-31 | 2019-03-07 | 学校法人早稲田大学 | コラーゲンへの結合活性を有する環状ペプチド |
| EP3681900A4 (en) | 2017-09-11 | 2021-09-08 | Protagonist Therapeutics, Inc. | OPIOID AGONIST PEPTIDES AND THEIR USES |
| WO2019157268A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| CA3104418A1 (en) | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2020311395A1 (en) | 2019-07-10 | 2022-02-03 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| MX2022008740A (es) | 2020-01-15 | 2022-09-23 | Janssen Biotech Inc | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. |
| SMT202500254T1 (it) | 2020-01-15 | 2025-09-12 | Janssen Biotech Inc | Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| KR20240034224A (ko) | 2021-07-14 | 2024-03-13 | 얀센 바이오테크 인코포레이티드 | 인터류킨-23 수용체의 지질화된 펩티드 억제제 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972890A (en) | 1988-05-02 | 1999-10-26 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
| EP0635029A4 (en) * | 1992-04-10 | 1996-01-24 | Gen Hospital Corp | MATRIX PROTEIN FROM CARTILAGE AND APPLICATION METHODS. |
| US7488792B2 (en) | 2002-08-28 | 2009-02-10 | Burnham Institute For Medical Research | Collagen-binding molecules that selectively home to tumor vasculature and methods of using same |
| GB0326546D0 (en) | 2003-11-14 | 2003-12-17 | Amersham Plc | Inhibitor imaging agents |
| GB0327494D0 (en) | 2003-11-26 | 2003-12-31 | Amersham Plc | Novel imaging agents |
| WO2005082941A1 (en) | 2004-02-27 | 2005-09-09 | The University Of Western Ontario | Bone sialoprotein collagen-binding peptides |
| US7575738B2 (en) | 2004-08-13 | 2009-08-18 | General Electric Company | Heat shock protein as a targeting agent for endothelium-specific in vivo transduction |
| GB0421308D0 (en) * | 2004-09-24 | 2004-10-27 | Amersham Plc | Enzyme inhibitor imaging agents |
| AU2005307195A1 (en) * | 2004-11-22 | 2006-05-26 | Ge Healthcare As | Contrast agents to target extracellular matrix |
-
2006
- 2006-05-25 GB GBGB0610395.6A patent/GB0610395D0/en not_active Ceased
-
2007
- 2007-05-25 RU RU2008146031/15A patent/RU2441668C2/ru not_active IP Right Cessation
- 2007-05-25 WO PCT/GB2007/001964 patent/WO2007138291A2/en not_active Ceased
- 2007-05-25 CN CN2007800192052A patent/CN101454026B/zh not_active Expired - Fee Related
- 2007-05-25 US US12/302,290 patent/US8304388B2/en not_active Expired - Fee Related
- 2007-05-25 BR BRPI0711937-2A patent/BRPI0711937A2/pt not_active IP Right Cessation
- 2007-05-25 JP JP2009511581A patent/JP2009537624A/ja not_active Ceased
- 2007-05-25 EP EP07732982A patent/EP2026844A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5784911B2 (ja) | ボンベシンアナログペプチドアンタゴニスト複合体 | |
| RU2008146031A (ru) | Новые визуализирующие агенты | |
| JP6824738B2 (ja) | 放射性トレーサー組成物及び方法 | |
| CN107382890A (zh) | 前列腺特异性膜抗原(psma)的同源多价抑制剂和异源多价抑制剂以及其用途 | |
| EP3956346A1 (en) | Novel radiolabelled cxcr4-targeting compounds for diagnosis and therapy | |
| CA3236432A1 (en) | Gastric inhibitory peptide receptor ligands | |
| KR20140012112A (ko) | 테크네튬 표지화 펩티드 | |
| WO2020249980A1 (en) | Compounds and methods of use | |
| CN121712789A (zh) | Fap靶向环肽及其缀合物 | |
| JP2019196356A (ja) | 精製方法及び組成物 | |
| JP6231882B2 (ja) | 放射性コンジュゲーション方法 | |
| KR102046437B1 (ko) | 방사성불소화 방법 | |
| JP6574997B2 (ja) | 金属錯体とそのフッ素化 | |
| JP2006508084A (ja) | Ｔｃ錯体と標的部分との複合体並びにＭＲＩ診断での使用 | |
| CN117396491A (zh) | 基于肽的新型诊断剂和治疗剂 | |
| JP2016532700A (ja) | 放射性標識方法 | |
| CN114845742A (zh) | 用于癌症成像和治疗的经改性的grpr拮抗剂肽 | |
| JP6280507B2 (ja) | キレート剤 | |
| JP2015086213A (ja) | 放射性核種標識オクトレオチド誘導体 | |
| JP4318985B2 (ja) | ソマトスタチンアナログ誘導体およびその利用 | |
| CN117320759A (zh) | 放射性药物生长抑素受体配体及其前体 | |
| CN108697767A (zh) | 包含用于成像目的的螯合部分的选择性胰高血糖素受体激动剂 | |
| CN105339013A (zh) | 金属络合物及其氟化 | |
| CN104854126A (zh) | 多肽及成像方法 | |
| WO2014096191A1 (en) | Bis 2h-imidazole-2-thione chelating agents as ligands for radiopharmaceutical in vivo imaging |